- Company Overview for PHEROSYN LTD (12434594)
- Filing history for PHEROSYN LTD (12434594)
- People for PHEROSYN LTD (12434594)
- More for PHEROSYN LTD (12434594)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
05 Feb 2025 | CS01 | Confirmation statement made on 29 January 2025 with updates | |
17 Dec 2024 | RESOLUTIONS |
Resolutions
|
|
12 Dec 2024 | SH01 |
Statement of capital following an allotment of shares on 7 August 2024
|
|
25 Jun 2024 | RESOLUTIONS |
Resolutions
|
|
21 Jun 2024 | SH01 |
Statement of capital following an allotment of shares on 7 June 2024
|
|
16 Jun 2024 | PSC08 | Notification of a person with significant control statement | |
13 Jun 2024 | PSC07 | Cessation of Mary Louise Ellis as a person with significant control on 7 June 2024 | |
13 May 2024 | AP01 | Appointment of Tina Elizabeth Lawton as a director on 1 May 2024 | |
13 Mar 2024 | SH01 |
Statement of capital following an allotment of shares on 21 February 2024
|
|
05 Feb 2024 | CS01 | Confirmation statement made on 29 January 2024 with updates | |
01 Feb 2024 | AP01 | Appointment of Dr David Kenneth Lawrence as a director on 23 January 2024 | |
31 Jan 2024 | TM01 | Termination of appointment of John Christopher Caulfield as a director on 23 January 2024 | |
31 Jan 2024 | TM01 | Termination of appointment of David Matthew Withall as a director on 23 January 2024 | |
17 Jan 2024 | MA | Memorandum and Articles of Association | |
16 Jan 2024 | SH01 |
Statement of capital following an allotment of shares on 22 December 2023
|
|
16 Jan 2024 | SH01 |
Statement of capital following an allotment of shares on 19 December 2023
|
|
16 Jan 2024 | SH01 |
Statement of capital following an allotment of shares on 16 December 2023
|
|
09 Jan 2024 | PSC01 | Notification of Mary Louise Ellis as a person with significant control on 16 December 2023 | |
08 Jan 2024 | PSC09 | Withdrawal of a person with significant control statement on 8 January 2024 | |
01 Jun 2023 | CH01 | Director's details changed for Dr Mary Louise Ellis on 16 May 2023 | |
16 May 2023 | AP01 | Appointment of Dr Mary Louise Ellis as a director on 16 May 2023 | |
11 May 2023 | CH01 | Director's details changed for Dr John Christopher Caulfield on 5 May 2023 | |
30 Mar 2023 | AA | Micro company accounts made up to 28 February 2023 | |
15 Mar 2023 | AA01 | Previous accounting period shortened from 31 March 2023 to 28 February 2023 | |
06 Feb 2023 | CS01 | Confirmation statement made on 29 January 2023 with updates |